Evidence map›Paper›PMID 42035209›Full record

Observational studyGenome medicine2026

Single base focal hypermutation cooccurs with structural variation as an early event in advanced prostate tumourigenesis with ancestry specific independence: a multi-ancestral observational study.

Jue Jiang, Avraam Tapinos, Ruotian Huang, M S Riana Bornman, Phillip D Stricker, Shingai B A Mutambirwa, David C Wedge, Weerachai Jaratlerdsiri, Vanessa M Hayes

Abstract readObservational Study
In one paragraph

Observational study in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jue JiangAncestry and Health Genomics Laboratory, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia.
Avraam TapinosManchester Cancer Research Centre, University of Manchester, Manchester, M20 4GJ, UK.
Ruotian HuangAncestry and Health Genomics Laboratory, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia.
M S Riana BornmanSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.
Phillip D StrickerSt Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Shingai B A MutambirwaDepartment of Urology, Sefako Makgatho Health Science University, George Mukhari Academic Hospital, Medunsa, Ga-Rankuwa, South Africa.
David C WedgeManchester Cancer Research Centre, University of Manchester, Manchester, M20 4GJ, UK.
Weerachai JaratlerdsiriAncestry and Health Genomics Laboratory, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia. weerachai.jaratlerdsiri@sydney.edu.au.
Vanessa M HayesAncestry and Health Genomics Laboratory, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia. vanessa.hayes@sydney.edu.au.

Funding

Genomic bases for African geo-ethnic prostate cancer health disparityR01CA285772 · NCI · UNIVERSITY OF SYDNEY · PI Vanessa Marie Hayes · 2024 to 2026
$1.5M
Congressionally Directed Medical Research Programs PC200390 (TARGET Africa)Congressionally Directed Medical Research Programs PC210168 and PC23067, HEROIC PCaPH Africa1KNational Health and Medical Research Council 2018/GNT1165762National Health and Medical Research Council 2024/GNT2037298NCI NIH HHS 1R01CA285772-01NCI NIH HHS R01 CA285772Petre Foundation Petre Chair (Hayes)Prostate Cancer Foundation 2023CHAL4150Prostate Cancer Foundation 23CHAL18
6 · The paper itself

Abstract

backgroundKataegis, the focal hypermutation of single base positions in tumour genomes, has received little attention with regards to prostate cancer (PCa) molecular features, tumour evolution and associated clinical presentation. Most notably, the impact of this phenomenon is yet to be explored across ancestral lineages representing the extremities of PCa presentation and outcomes, with men of African ancestry disproportionately disadvantaged. The purpose of this study is to address the knowledge gap through African inclusive multi-ancestral interrogation.

methodsWe assessed for ancestrally shared and unique molecular, evolutionary and clinical features of kataegis in 669 multi-ancestral whole PCa genomes. Access to raw whole-genome sequenced data allowed for direct single-pipeline comparative analysis between 109 southern African and 57 European derived treatment naïve high-risk-biased primary tumours (74% and 88%) with paired blood samples, further assessed against publicly available 207 Asian high-risk-leaning comparative (65%) and 296 European low-risk-biased alternative (79%) resources. Comparisons between ancestries and risk groups were through Wilcoxon’s rank sum test and Fisher’s exact tests, with P values adjusted by false discovery rate.

resultsConfirming relatively low burdens, we found kataegis to be significantly associated with genomic instability, cancer drivers, and clinical adversity across ancestries (false discovery rate = [Formula: see text]). Notably, kataegis-postive tumours were associated with elevated prostate-specific antigen levels at presentation in African (false discovery rate = [Formula: see text]) and higher risk for metastatic progression in European patients (Kaplan-Meier estimator, [Formula: see text]). Enrichment of APOBEC’s context preferences showed more attribution from APOBEC3B than APOBEC3A. Further through analyses of evolution and structural variant (SV) co-occurrence, commonly the ancestry agnostic SV-associated kataegis predominated in the clonal evolutionary state, while the less common the SV-independent kataegis ([Formula: see text]) and subclonal kataegis ([Formula: see text]) showed African specificity.

conclusionsWe found kataegis-positivity to be associated with poor PCa presentation and prognosis, irrespective of patient ancestry. Kataegis-related genomic instability occurring early and late during African derived tumourigenesis, may partly explain the heightened tumour and clinical heterogeneity observed for patients of African ancestry.

Indexed as

CarcinogenesisMutationProstatic NeoplasmsAfrican PeopleHumansMaleWhiteWhite PeopleAncestral disparityAPOBECCancer evolutionKataegisProstate cancer

Identifiers

PMID42035209
PMCPMC13281657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.